President Donald Trump has dramatically escalated his campaign against high medicine costs. He issued a stark ultimatum to 17 of the world’s leading pharmaceutical firms. In a move aimed at achieving lower pharmaceutical prices, the President demanded that they slash prices for American consumers. He wants them to match what is paid in other developed nations, setting a 60-day deadline…
Tag: PhRMA
-
New Pharmaceutical Tariffs: An Industry at Risk
A Temporary Reprieve from New Tariffs In a significant, albeit potentially temporary, development for one of the nation’s most critical sectors, the US pharmaceutical industry has successfully avoided the immediate impact of new pharmaceutical tariffs under President Donald Trump’s recent broad trade measures. This initial exemption has provided a moment of relief, allowing complex global supply chains to continue functioning…